EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III)

Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"

NCT00792753 ·Status: COMPLETED ·Phase: NA

Clinical Study to Evaluate the STENTYS Xposition S for Treatment of Unprotected Left Main Coronary Artery Disease

NCT02800837 ·Status: UNKNOWN

China Made Sirolimus Eluting Stent for Intermediate Lesion

NCT01375296 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions

NCT07022587 ·Status: RECRUITING ·Phase: NA

Drug- Eluting Stent for Symptomatic Intracranial Arterial Stenosis

NCT07197970 ·Status: RECRUITING ·Phase: PHASE3

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)

NCT01078038 ·Status: COMPLETED ·Phase: PHASE4

DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold

NCT03074305 ·Status: WITHDRAWN ·Phase: NA

Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions

NCT02360709 ·Status: UNKNOWN

Excel Drug-Eluting Stent Pilot Clinical Registry

NCT00385905 ·Status: COMPLETED ·Phase: PHASE4

Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease

NCT01294748 ·Status: COMPLETED ·Phase: PHASE2

DCB vs DES for Severe Coronary Calcification After Optimal Modification Assessed by QFR

NCT07277114 ·Status: RECRUITING ·Phase: NA

Efficacy and Safety of Firebird 2 Stent in Treatment of Complex Coronary Lesions in Diabetes

NCT01257373 ·Status: UNKNOWN

Outcome of Second Generation Drug-eLuting Stents in Patients With Diabetes Mellitus

NCT01293773 ·Status: WITHDRAWN ·Phase: PHASE4

Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions

NCT02360423 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

NCT02698852 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions

NCT02542007 ·Status: COMPLETED ·Phase: NA

DESyne X2 Post Market Follow-up Study

NCT04375085 ·Status: TERMINATED ·Phase: NA

Drug-coated Balloon Versus Drug-eluting Stent in the Treatment of Coronary Artery Lesions in STEMI Patients in De Novo Coronary Lesions

NCT04072081 ·Status: UNKNOWN ·Phase: NA

The Efficacy and Safety of Intracranial Self-expanding DES in Symptomatic Intracranial Atherosclerotic Disease

NCT05217459 ·Status: COMPLETED ·Phase: NA

Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions

NCT04561739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Assess the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease

NCT02946307 ·Status: COMPLETED ·Phase: NA

Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined With Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: a Prospective, Randomized, Controlled Clinical Trial

NCT03589157 ·Status: UNKNOWN ·Phase: NA

A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT

NCT03716011 ·Status: NOT_YET_RECRUITING ·Phase: NA

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

NCT00232739 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease

NCT02216058 ·Status: UNKNOWN ·Phase: NA